TGI
JNCE
TRV GP II’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $1.34M | Sell |
572,829
-775,000
| -57% | -$1.81M | 100% | 1 |
|
|
2022
Q2 | $4.08M | Hold |
1,347,829
| – | – | 88.46% | 1 |
|
|
2022
Q1 | $9.15M | Sell |
1,347,829
-1,350,000
| -50% | -$9.17M | 93.42% | 1 |
|
|
2021
Q4 | $22.5M | Hold |
2,697,829
| – | – | 93.16% | 1 |
|
|
2021
Q3 | $20M | Sell |
2,697,829
-1,750,000
| -39% | -$13M | 88.84% | 1 |
|
|
2021
Q2 | $30.2M | Sell |
4,447,829
-2,052,520
| -32% | -$14M | 89.29% | 1 |
|
|
2021
Q1 | $66.8M | Sell |
6,500,349
-2,700,000
| -29% | -$27.7M | 42.19% | 2 |
|
|
2020
Q4 | $64.4M | Sell |
9,200,349
-1,030,000
| -10% | -$7.21M | 44.86% | 2 |
|
|
2020
Q3 | $83.5M | Hold |
10,230,349
| – | – | 54.19% | 1 |
|
|
2020
Q2 | $70.6M | Hold |
10,230,349
| – | – | 52.18% | 1 |
|
|
2020
Q1 | $48.6M | Hold |
10,230,349
| – | – | 52.19% | 1 |
|
|
2019
Q4 | $89.3M | Hold |
10,230,349
| – | – | 92.14% | 1 |
|
|
2019
Q3 | $34.1M | Hold |
10,230,349
| – | – | 75.6% | 1 |
|
|
2019
Q2 | $50.6M | Hold |
10,230,349
| – | – | 81.68% | 1 |
|
|
2019
Q1 | $63.4M | Hold |
10,230,349
| – | – | 41.35% | 2 |
|
|
2018
Q4 | $34.5M | Hold |
10,230,349
| – | – | 34.25% | 2 |
|
|
2018
Q3 | $66.5M | Hold |
10,230,349
| – | – | 39.03% | 2 |
|
|
2018
Q2 | $78.4M | Hold |
10,230,349
| – | – | 44.43% | 1 |
|
|
2018
Q1 | $229M | Hold |
10,230,349
| – | – | 42.85% | 1 |
|
|
2017
Q4 | $130M | Buy |
+10,230,349
| New | +$130M | 23.49% | 2 |
|